Abstract
Five yogurts were fermented with each bacteria strain. The viability and pH of each yogurt during fermentation or storage were evaluated, and then the cytotoxicity and antiviral activity against enterovirus (EV) 71 of cell-free supernatants (CFS) of the metabolites of each yogurt were compared with those of de Man, Rogosa, and Sharpe (MRS) broth fermented with the same bacteria. As the results, the number of viable bacteria for each yogurt after fermentation or during storage always remained higher than 5 log CFU/mL and the pH of those ranged from 4 to 6. The CFS of all yogurts showed antiviral activity over 45% against EV71, while it didn’t exhibit cytotoxicity in Vero cells. Specially, the CFS of yogurt fermented with Lactobacillus plantarum and Bifidobacterium bifidum exhibited high anti-EV71 activity of 92.74 and 90.44%, respectively. In contrast, the CFS of each MRS broth fermented with the same bacteria showed low antiviral activity of less than 30%.
This is a preview of subscription content, access via your institution.
References
McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26: 91–107 (2002)
Chang LY, Lee CY, Kao CL, Fang TY, Lu CY, Lee PI, Huang LM. Hand, foot, and mouth disease complicated with central nervous system involvement in Taiwan in 1980–1981. J. Formosan Med. Assoc. 106: 173–176 (2007)
Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133: 795–798 (1998)
Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J. Clin. Microbiol. 43: 6171–6175 (2005)
Wong KT, Lum LC, Lam SK. Enterovirus 71 infection and neurologic complications. New Eng. J. Med. 342: 356–358 (2000)
Chang LY, Lin TY, Huang YC. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352: 367–368 (1998)
Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. New Eng. J. Med. 341: 929–935 (1999)
Lin SJ, Yeh TF. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29: 184–190 (1999)
Sanders ME. Lactic acid bacteria as promoters of human health. pp. 294–322. In: Functional Foods. Goldberg L (ed). Chapman and Hall Company, New York, NY, USA (1997)
Vasiljevic T, Shah NP. Fermented milk: Health benefits beyond probiotic effect. pp. 99–116. In: Handbook of Food Product Manufacturing. Hui YH (ed). John Wiley & Sons Incorporated, Hoboken, NJ, USA (2007)
Schezenmeir J, De Vrese M. Probiotics, prebiotics, and synbiotics: Approaching a definition. Am. J. Clin. Nutr. 73: 361S–364S (2001)
Corcoran BM, Stanton C, Fitzgerald GF, Ross RP. Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl. Environ. Microb. 71: 3060–3067 (2005)
Lin W, Hwang C, Chen L, Tsen H. Viable counts, characteristic evaluation for commercial lactic acid bacteria products. Food Microbiol. 23: 74–81 (2006)
Boti cell culture model to study antiviral activity of potential probiotic bacteria. Int. J. Food Microbiol. 115: 227–234 (2007)
Lin ZX, Hoult JRS, Raman A. Sulforhodamine B assay for measuring proliferation of a pigmented melanocyte cell line and its application to the evalution of crude drugs used in the treatment of vitiligo. J. Ethnopharmacol. 66: 141–150 (1999)
Dave RI, Shah NP. Viability of yoghurt and probiotic bacteria in yoghurts made from commercial starter cultures. Int. Dairy J. 7: 31–41 (1997)
Gilliland SE, Speck ML. Instability of L. acidophilus in yoghurt. J. Dairy Sci. 60: 1394–1398 (1997)
Kneifel W, Jaros D, Erhard F. Microflora and acidification properties of yoghurt and yoghurt related products fermented with commercially available starter cultures. Int. J. Food Microbiol. 18: 179–189 (1993)
Kurmann JA, Rasic JL. The health potential of products containing bifidobacteria. pp. 117–158. In: Therapeutic Properties of Fermented Milks. Robinson RK (ed). Elsevier Applied Food Science Series, London, UK (1991)
Samona A Robinson RK. Effect of yogurt cultures on the survival of bifidobacteria in fermented milks. J. Soc. Dairy Technol. 47: 58–60 (1994)
Beaulieu J, Dupont C, Lemieux P. Whey proteins and peptides: Beneficial effects on immune health. Therapy 3: 1–10 (2006)
Sanders ME, Huis in’t Veld J. Bringing a probiotic containing functional food to the market: Microbiological, product, regulatory, and labeling issues. Anton Leeuw. Int. J. G. 76: 293–315 (1999)
Schaller JP, Saif LJ, Cordle CT, Candler E, Winship TR, Smith KL. Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J. Infect. Dis. 165: 623–630 (1992)
Berkhout B, van Wamel JL, Beljaars L, Meijer DK, Visser S, Floris R. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antivir. Res. 55: 341–355 (2002)
Ng TB, Lam TL, Au TK, Ye XY, Wan CC. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease, and integrase by bovine milk proteins. Life Sci. 69: 2217–2223 (2001)
Wang H, Ye X, Ng TB. First demonstration of an inhibitory activity of milk proteins against immunodefiency virus-1 reverse transcriptase and effect of succinylation. Life Sci. 67: 2745–2752 (2000)
Adibi SA, Morse EL. Intestinal transport of dipeptides in man: Relative importance of hydrolysis and intact absorption. J. Clin. Invest. 50: 2266–2275 (1971)
Hara H, Funabiki R, Iwata M, Yamazaki K. Portal absorption of small peptides in rats under unrestrained conditions. J. Nutr. 114: 1122–1129 (1984)
Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, Shimizu M. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci. Biotech. Bioch. 66: 378–384 (2002)
Möller NP, Elisabeth K, Scholz-Ahens RN, Schezenmeir J. Bioactive peptides and proteins from foods: Indication for health effects. Eur. J. Nutr. 47: 171–182 (2008)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, HJ., Song, JH., Park, KS. et al. Antiviral activity of yogurt against enterovirus 71 in vero cells. Food Sci Biotechnol 19, 289–295 (2010). https://doi.org/10.1007/s10068-010-0042-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-010-0042-x